Basal cell carcinoma of skin, unspecified
ICD-10 C44.91 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin, unspecified.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. It is typically associated with prolonged sun exposure, particularly in fair-skinned individuals. BCCs are characterized by slow growth and a low likelihood of metastasis, making them less aggressive than other skin cancers. However, they can cause significant local tissue destruction if left untreated. The unspecified designation indicates that the specific location of the carcinoma on the skin is not documented, which can complicate treatment planning and coding. Surgical excision is the primary treatment modality, with margins of healthy tissue often removed to ensure complete resection. Reconstruction may be necessary depending on the size and location of the tumor, particularly in cosmetically sensitive areas such as the face. Accurate coding requires careful documentation of the tumor's characteristics, treatment approach, and any complications that arise during the management of the condition.
Detailed descriptions of the tumor's size, location, and histological type, along with treatment plans.
Diagnosis and treatment of BCC, including Mohs micrographic surgery and follow-up care.
Ensure clear documentation of margins and any reconstructive procedures performed.
Comprehensive treatment plans, including chemotherapy or radiation if applicable.
Management of advanced BCC cases or those requiring multidisciplinary approaches.
Documentation should reflect the oncological treatment rationale and outcomes.
Used for excising basal cell carcinoma with margins.
Document the size of the lesion and margins taken.
Dermatologists should ensure detailed operative notes.
The 'unspecified' designation indicates that the exact location of the basal cell carcinoma is not documented, which can affect treatment planning and coding accuracy.
